CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
More types of non-Hodgkin lymphoma
A
Adult T-cell leukemia/lymphoma
Aggressive NK-cell leukemia
AIDS-related lymphoma
Anaplastic large cell lymphoma
Angioimmunoblastic T-cell lymphoma
C
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Cutaneous T-cell lymphoma
D
Diffuse large B-cell lymphoma
E
Enteropathy-associated T-cell lymphoma
Extranodal NK/T-cell lymphoma - nasal type
H
Hepatosplenic T-cell lymphoma
I
Intravascular large B-cell lymphoma
L
Lymphoblastic lymphoma
Lymphoplasmacytic lymphoma
M
MALT lymphoma
Mantle cell lymphoma
P
Peripheral T-cell lymphoma
Post-transplant lymphoproliferative disorder
Primary CNS lymphoma
Primary effusion lymphoma
Primary mediastinal large B-cell lymphoma
Prolymphocytic leukemias
S
Splenic marginal zone lymphoma
Subcutaneous panniculitis-like T-cell lymphoma
Investing to reduce cancer burden

Last year CCS funded $40 million in cancer research, thanks to our donors. Discover how you can help reduce the burden of cancer.